Zobrazeno 1 - 10 of 40 pro vyhledávání: '"Stanciu, AE"'
1
Akademický článek
Hairy polyp of the rhinopharynx - a rare and unrecognized entity.
Autor: GHEORGHE, Dan Cristian1,2 gheorghe.dancristian@gmail.com, ZAMFIR-CHIRU-ANTON, Adina3, ENE, LE4, STANCIU, AE2,5
Publikováno v: Romanian Journal of Medical Practice. 2020, Vol. 15 Issue 1, p112-114. 3p.
Zobrazit plný text záznamu
2
Akademický článek
PIRIFORM SINUS FISTULA MANAGEMENT APROACH - OUR EXPERIENCE.
Autor: Gheorghe, Dan Cristian1,2 gheorghe.dancristian@gmail.com, Zamfir-Chiru-Anton, Adina3, Ene, LE4, Stanciu, AE2,5
Publikováno v: Romanian Medical Journal. 2020, Vol. 67 Issue 1, p99-101. 3p. 2 Black and White Photographs.
Zobrazit plný text záznamu
3
Akademický článek
HUNTER SYNDROME REVISITED.
Autor: Gheorghe, Dan Cristian1,2, Zamfir-Chiru-Anton, Adina3, Ene, LE4, Stanciu, AE2,5
Publikováno v: Romanian Medical Journal. 2020, Vol. 67 Issue 1, p87-89. 3p. 1 Color Photograph, 1 Black and White Photograph.
Zobrazit plný text záznamu
4
Report
Eustachian Tube Teratoma: A Rare Entity.
Autor: Gheorghe DC; ENT Department, 'MarieCurie' Children Hospital, 'Carol Davila' University, Bucharest, Romania., Enculescu A; Pathology Department, 'Marie Curie' Children Hospital, Bucharest, Romania., Stanciu AE; Department of Carcinogenesis and Molecular Biology, Institute of Oncology Bucharest, Bucharest, Romania., Epure V; ENT Department, 'MarieCurie' Children Hospital, 'Carol Davila' University, Bucharest, Romania., Zamfir-Chiru-Anton A; ENT Department, 'Grigore Alexandrescu' Emergency Hospital for Children, Bucharest, Romania.
Publikováno v: Clinical pathology (Thousand Oaks, Ventura County, Calif.) [Clin Pathol] 2023 Aug 17; Vol. 16, pp. 2632010X231195231. Date of Electronic Publication: 2023 Aug 17 (Print Publication: 2023).
Zobrazit plný text záznamu
5
Akademický článek
Portrait of the Inflammatory Response to Radioiodine Therapy in Female Patients with Differentiated Thyroid Cancer with/without Type 2 Diabetes Mellitus.
Autor: Stanciu AE; Department of Carcinogenesis and Molecular Biology, Institute of Oncology Bucharest, 022328 Bucharest, Romania., Hurduc A; Department of Radionuclide Therapy, Institute of Oncology Bucharest, 022328 Bucharest, Romania., Stanciu MM; Electrical Engineering Faculty, University Politehnica of Bucharest, 060042 Bucharest, Romania., Gherghe M; Nuclear Medicine Department, Institute of Oncology Bucharest, 022328 Bucharest, Romania.; Nuclear Medicine Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania., Gheorghe DC; ENT Department, 'Maria Sklodowska Curie' Children's Emergency Hospital, 077120 Bucharest, Romania.; ENT Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania., Prunoiu VM; Oncological Surgery Department, Institute of Oncology Bucharest, 022328 Bucharest, Romania.; Oncological Surgery Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania., Zamfir-Chiru-Anton A; ENT Department, 'Grigore Alexandrescu' Children's Emergency Hospital, 011743 Bucharest, Romania.
Publikováno v: Cancers [Cancers (Basel)] 2023 Jul 26; Vol. 15 (15). Date of Electronic Publication: 2023 Jul 26.
Zobrazit plný text záznamu
6
Akademický článek
Correlation Studies between S100 Protein Level and Soluble MIA or Tissue MelanA and gp100 (HMB45) Expression in Cutaneous Melanoma.
Autor: Bolovan LM; Carcinogenesis and Molecular Biology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Ceausu M; Pathology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Stanciu AE; Carcinogenesis and Molecular Biology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Panait ME; Cancer Biology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Busca A; Cancer Biology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Hotnog CM; Center of Immunology, 'Stefan S. Nicolau' Institute of Virology, Romanian Academy, 030304 Bucharest, Romania., Bleotu C; Cellular and Molecular Pathology Department, 'Stefan S. Nicolau' Institute of Virology, Romanian Academy, 030304 Bucharest, Romania., Gales LN; Oncology Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Oncology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 252 Fundeni Ave, 022328 Bucharest, Romania., Georgescu MT; Oncology Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Oncology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 252 Fundeni Ave, 022328 Bucharest, Romania., Prunoiu VM; Oncological Surgery Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Oncological Surgery Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Brasoveanu LI; Center of Immunology, 'Stefan S. Nicolau' Institute of Virology, Romanian Academy, 030304 Bucharest, Romania., Voinea SC; Oncological Surgery Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Oncological Surgery Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania.
Publikováno v: Journal of personalized medicine [J Pers Med] 2023 May 26; Vol. 13 (6). Date of Electronic Publication: 2023 May 26.
Zobrazit plný text záznamu
7
Akademický článek
Quantitative Assessment of Treatment Response in Metastatic Breast Cancer Patients by SPECT-CT Bone Imaging-Getting Closer to PET-CT.
Autor: Gherghe M; Nuclear Medicine Department, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 București, Romania.; Nuclear Medicine Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Mutuleanu MD; Nuclear Medicine Department, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 București, Romania.; Nuclear Medicine Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Stanciu AE; Carcinogenesis and Molecular Biology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Irimescu I; Nuclear Medicine Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Lazar AM; Nuclear Medicine Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Toma RV; Oncology Department, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania.; Radiotherapy I Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Trifanescu OG; Oncology Department, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania.; Radiotherapy II Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Anghel RM; Oncology Department, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania.; Radiotherapy II Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania.
Publikováno v: Cancers [Cancers (Basel)] 2023 Jan 23; Vol. 15 (3). Date of Electronic Publication: 2023 Jan 23.
Zobrazit plný text záznamu
8
Akademický článek
Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact?
Autor: Gherghe M; Nuclear Medicine Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Nuclear Medicine Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania., Lazar AM; Nuclear Medicine Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania., Mutuleanu MD; Nuclear Medicine Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Nuclear Medicine Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania., Bordea CI; Surgical Oncology Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Surgical Oncology Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania., Ionescu S; Surgical Oncology Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania.; General Surgery Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania., Mihaila RI; Oncology Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania., Petroiu C; Nuclear Medicine Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania., Stanciu AE; Carcinogenesis and Molecular Biology Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania.
Publikováno v: Cancers [Cancers (Basel)] 2022 Dec 29; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 29.
Zobrazit plný text záznamu
9
Report
Moebius syndrome-Case report.
Autor: Gheorghe DC; Carol Davila University of Medicine and Pharmacy Bucharest Romania.; ENT Department 'MS Curie' Hospital Bucharest Romania., Stanciu AE; Institute of Oncology Bucharest Department of Carcinogenesis and Molecular Biology Bucharest Romania., Zamfir-Chiru-Anton A; 'Grigore Alexandrescu' Children's Emergency Hospital ENT Department Bucharest Romania., Doru O; ENT Department 'MS Curie' Hospital Bucharest Romania., Epure V; Carol Davila University of Medicine and Pharmacy Bucharest Romania.; ENT Department 'MS Curie' Hospital Bucharest Romania.
Publikováno v: Clinical case reports [Clin Case Rep] 2022 Dec 13; Vol. 10 (12), pp. e6715. Date of Electronic Publication: 2022 Dec 13 (Print Publication: 2022).
Zobrazit plný text záznamu
10
Akademický článek
The New Radiolabeled Peptide 99m TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?
Autor: Gherghe M; Nuclear Medicine Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Nuclear Medicine Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Lazăr AM; Nuclear Medicine Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Stanciu AE; Carcinogenesis and Molecular Biology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Mutuleanu MD; Nuclear Medicine Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Nuclear Medicine Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Sterea MC; Nuclear Medicine Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Petroiu C; Nuclear Medicine Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Galeș LN; Oncology Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Oncology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania.
Publikováno v: Cancers [Cancers (Basel)] 2022 May 31; Vol. 14 (11). Date of Electronic Publication: 2022 May 31.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje